Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,962 | 715 | 99.9% |
| Education | $11.00 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,331 | 134 | $0 (2024) |
| ABBVIE INC. | $1,069 | 68 | $0 (2024) |
| Lilly USA, LLC | $919.50 | 85 | $0 (2024) |
| Merck Sharp & Dohme LLC | $676.11 | 52 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $573.92 | 34 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $474.10 | 33 | $0 (2023) |
| Radius Health, Inc. | $474.09 | 27 | $0 (2024) |
| Amgen Inc. | $473.36 | 34 | $0 (2024) |
| PFIZER INC. | $385.75 | 27 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $358.48 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,212 | 64 | ABBVIE INC. ($332.63) |
| 2023 | $1,373 | 82 | ABBVIE INC. ($213.65) |
| 2022 | $1,155 | 79 | ABBVIE INC. ($166.35) |
| 2021 | $1,114 | 74 | Novo Nordisk Inc ($147.39) |
| 2020 | $906.85 | 67 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($176.04) |
| 2019 | $1,228 | 90 | Novo Nordisk Inc ($189.75) |
| 2018 | $1,358 | 105 | Novo Nordisk Inc ($220.99) |
| 2017 | $1,626 | 156 | Novo Nordisk Inc ($355.57) |
All Payment Transactions
717 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Seqirus USA Inc | Flucelvax (Biological), Fluad | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Vaccines | ||||||
| 11/08/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Diabetes | ||||||
| 10/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Endocrinology | ||||||
| 10/04/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Oncology | ||||||
| 09/30/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: VACCINE | ||||||
| 09/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.07 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.27 | General |
| Category: Cardiovascular | ||||||
| 08/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: PAIN | ||||||
| 08/19/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Diagnostics | ||||||
| 08/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: RESPIRATORY | ||||||
| 07/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Diabetes | ||||||
| 07/19/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Diabetes | ||||||
| 07/12/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: NEUROSCIENCE | ||||||
| 07/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Cardio-renal | ||||||
| 06/27/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: NEUROSCIENCE | ||||||
| 06/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 241 | 393 | $40,140 | $22,600 |
| 2022 | 9 | 310 | 451 | $45,490 | $26,279 |
| 2021 | 12 | 353 | 516 | $47,200 | $27,573 |
| 2020 | 9 | 302 | 477 | $43,915 | $22,492 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 75 | 178 | $24,920 | $14,617 | 58.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 54 | 86 | $9,890 | $5,155 | 52.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 29 | $2,030 | $1,078 | 53.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 27 | 28 | $980.00 | $822.08 | 83.9% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 29 | 30 | $1,200 | $613.80 | 51.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 22 | 28 | $980.00 | $266.56 | 27.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 13 | 14 | $140.00 | $47.74 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 80 | 186 | $26,040 | $15,565 | 59.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 47 | 60 | $6,900 | $3,568 | 51.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 22 | $4,400 | $2,813 | 63.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 47 | 57 | $3,990 | $2,365 | 59.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 30 | 30 | $1,050 | $838.50 | 79.9% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 30 | 30 | $1,200 | $602.10 | 50.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 32 | 38 | $1,330 | $363.43 | 27.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 12 | $420.00 | $109.76 | 26.1% |
| 81002 | Urinalysis, manual test | Office | 2022 | 15 | 16 | $160.00 | $54.93 | 34.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 72 | 177 | $24,690 | $15,500 | 62.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 36 | 47 | $5,355 | $3,043 | 56.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 44 | 57 | $3,960 | $2,088 | 52.7% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 15 | 16 | $2,420 | $1,991 | 82.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 20 | 20 | $3,955 | $1,987 | 50.2% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent | Office | 2021 | 51 | 52 | $2,080 | $1,035 | 49.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 51 | 52 | $1,820 | $841.88 | 46.3% |
| 87804 | Detection test by immunoassay for influenza virus | Office | 2021 | 11 | 25 | $875.00 | $413.75 | 47.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 15 | 16 | $560.00 | $258.68 | 46.2% |
About Dr. Debra Fast, DO
Dr. Debra Fast, DO is a Internal Medicine healthcare provider based in Wooster, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1184624496.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Debra Fast, DO has received a total of $9,973 in payments from pharmaceutical and medical device companies, with $1,212 received in 2024. These payments were reported across 717 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($9,962).
As a Medicare-enrolled provider, Fast has provided services to 1,206 Medicare beneficiaries, totaling 1,837 services with total Medicare billing of $98,944. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Wooster, OH
- Active Since 07/28/2005
- Last Updated 04/01/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1184624496
Products in Payments
- XIFAXAN (Drug) $563.80
- Ozempic (Drug) $533.43
- JARDIANCE (Drug) $446.79
- UBRELVY (Drug) $443.22
- Victoza (Drug) $371.00
- ELIQUIS (Drug) $298.00
- MOUNJARO (Drug) $284.43
- FARXIGA (Drug) $256.14
- Tymlos (Biological) $255.33
- NURTEC ODT (Drug) $245.40
- JANUVIA (Drug) $231.05
- Vascepa (Drug) $229.35
- VRAYLAR (Drug) $225.28
- Tymlos (Drug) $218.76
- SYMBICORT (Drug) $200.28
- EMGALITY (Drug) $199.55
- Kerendia (Drug) $188.28
- EVENITY (Biological) $167.57
- Aimovig (Biological) $158.47
- PNEUMOVAX 23 (Biological) $137.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Wooster
Kathleen Fearon, Do, DO
Internal Medicine — Payments: $8,946
Dana Bonezzi, Md, MD
Internal Medicine — Payments: $5,789
Alycia Findlay, M.d, M.D
Internal Medicine — Payments: $1,654
Ruta Semaskiene, Md, MD
Internal Medicine — Payments: $543.63
Loren Kirchner, Md, MD
Internal Medicine — Payments: $329.71
Mrs. Rosa Cleaver, Aprn, Fnp-C, APRN, FNP-C
Internal Medicine — Payments: $292.31